Hong Kong Stock Announcement Highlights: Ping An's First Three Quarters Net Profit Attributable to Shareholders Reaches 96.645 Billion Yuan, Continues to Deepen "Comprehensive Finance + Healthcare and Elderly Care" Dual-Wheel Parallel, Technology-Driven Strategy

Stock News09:10

Major Developments:

Ascletis Pharma-B (01672): GLP-1 oral small molecule ASC30 achieved a placebo-corrected HbA1c reduction of 1.7% at week 12 in U.S. Phase II study in diabetic subjects. Junshi Biosciences (01877): Toripalimab received regular approval from the National Medical Products Administration for the treatment of locally advanced or metastatic urothelial carcinoma that has failed platinum-containing chemotherapy. Bo Leiton (01333) and Jinchengjian intend to establish a long-term cooperative relationship in the field of green energy and intelligent mining industry synergy in the Democratic Republic of Congo. Hengrui Pharma (01276): HRS-8046 tablets approved to conduct clinical trials. Guotai Haitong (02611) subsidiary approved to establish Shanghai Linghang Kechuang Fund Partnership (Limited Partnership). Concord New Energy (00182) subsidiary intends to sell 100% equity of Gail Mountain and Grape Creek for up to approximately US$29.98 million. CSPC Pharmaceutical (01093): Phase I clinical trial of SYS6077 injection for the treatment of advanced malignant tumors officially launched at China's first research center.

Operating Performance:

Jiangxi Copper (00358) reported net profit attributable to shareholders of 11.687 billion yuan in the first three quarters, a year-on-year increase of 94.02%. Hopson Development Holdings (00754) released its 2025 annual results, with losses attributable to shareholders of HK$11.741 billion. Topsports (06110) released its interim results, with profit attributable to shareholders of 663 million yuan, increasing investment in new brand matrix to expand incremental space. PetroChina (00857) reported net profit attributable to shareholders of 155.776 billion yuan in the first three quarters, a year-on-year increase of 21.9%. OmniVision Group (00501) expects fourth quarter operating revenue of 7.759 billion yuan to 8.324 billion yuan, a year-on-year increase of 9.71% to 17.71%. AsiaInfo Technologies (01675) reported revenue of approximately 3.38 billion yuan in the first three quarters, with non-operator market order contract value achieving doubled growth. CGN Power (01816) reported net profit attributable to shareholders of approximately 9.603 billion yuan in the first three quarters, a year-on-year increase of 12.75%. Ping An Insurance (Group) Company Of China, Ltd. (02318) reported net profit attributable to shareholders of 96.645 billion yuan in the first three quarters, continuing to deepen the "comprehensive finance + healthcare and elderly care" dual-wheel parallel, technology-driven strategy. China Pacific Insurance (02601) reported net profit of 36.403 billion yuan in the first three quarters, a year-on-year decrease of 20.3%. Standard Chartered Group (02888) released its third quarter results, with profit before tax of US$2.3 billion, a year-on-year increase of 29%. China Overseas Land & Investment (00688) reported revenue of 130.4 billion yuan in the first three quarters and operating profit of 14.49 billion yuan.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment